维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="MARCHION D"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Development of histone deacetylase inhibitors for cancer treatment 显示文摘	Marchion D Munster P	2007	Expert Rev Anticancer Ther2007，7，：	1
	2	Gas- phase NMR studies of the thermolysis of perfluo-rooctanoic acid 显示文摘	KRUSIC P J MARCHIONE A A ROE D C	2005	J Fluorine Chem2005，126，：	1
	3	Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker显示文摘	Munster P N Marchion D Thomas S	2009	Br J Cancer2009，101，7：	1
	4	Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study显示文摘	Mster P Marchion D Bicaku E	2007	J Clin Oncol2007，2025，15：	1
	5	Functional disruption in the organization of the brain for reading and dyslexia显示文摘	SHAYWITZ S E SHAYWITZ B A PUGH K R FULBRIGHT R K CONSTABLE R T MENCL W E SHANKWEILER D P LIBERMAN A M SKUDLARSKI P FLETCHER J M KATZ L MARCHIONE K E LACADIE C GATENBY C GORE J C	1998	Proceeding of the National Academy of Sciences of the United States of America1998，95，：	1
	6	Phase I trial of histone deacetylase inhibition by valproie acid followed by the topoisomerase Ⅱ inhibitor epirubicin in advanced solid tumors: a clinical and translational study 显示文摘	MUNSTER P MARCHION D BICAKU E	2007	J Clin Oncol2007，25，15：	1
	7	Development of histone deacetylase inhibitors for cancer treatment 显示文摘	Marchion D Mtinster P	2007	Expert Rev Anticancer Ther2007，7，：	1
	8	HDAC2regulates chromatin plasticity and enhances DNA vulner-ability 显示文摘	Marchion D C Bicaku E Turner J G	2009	Mol Cancer Ther2009，8，4：	1
	9	Development of histone deacetylase inhibitors for cancer treatment 显示文摘	Marchion D Munster P	2007	Expert Rev Anticancer Ther2007，7，4：	1
	10	Development of histone deacetylase inhibitors for cancer treatment显示文摘	Marchion D Münster P	2007	Expert Rev Anticancer Ther2007，7，4：	1
	11	Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker显示文摘	Munster PN Marchion D Thomas S	2009	Br J Cancer2009，101，7：	1
	12	Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase I] inhibitor epirubicin in advanced solid tumors: a clinical and translational study显示文摘	Mtinster P Marchion D Bicaku E	2007	J Clin Oncol2007，25，15：	1
	13	Gas-phase NMR studies of the thermolysis of perfluorooctanoic acid显示文摘	Krusic P J Marchione A A Roe D C	2005	Fluorine Chem2005，126，：	1
	14	Development of histone deacetylase inhibitors for cancer treatment 显示文摘	MARCHION D MUNSTER P	2007	Expert Rev Anticancer Ther2007，7，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费